Building an Operational Framework for Post-Trial Access

• Translating Post-Trial Access strategy into a practical operational framework that can be applied consistently across programs
• Defining the processes, roles and cross-functional responsibilities needed to operationalize Post-Trial Access effectively
• Sharing practical examples and lessons learned from managing Post-Trial Access, including common hurdles and how they have been overcome
• Building a framework that supports consistent decision-making while allowing teams to respond to different program and country requirements

Speakers:

Anh Tran

Executive Director, Clinical Operations Late Phase Lead

Alexion Pharmaceuticals

Tania Azad

Global Program Director, Late Phase Clinical Operations

Alexion Pharmaceuticals